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In experimental elastase-induced emphysema, mechanical ventilation with variable tidal
volumes (VT) set to 30% coefficient of variation (CV) may result in more homogenous
ventilation distribution, but might also impair right heart function. We hypothesized that a
different CV setting could improve both lung and cardiovascular function. Therefore, we
investigated the effects of different levels of VT variability on cardiorespiratory function,
lung histology, and gene expression of biomarkers associated with inflammation,
fibrogenesis, epithelial cell damage, andmechanical cell stress in this emphysemamodel.
Wistar rats (n = 35) received repeated intratracheal instillation of porcine pancreatic
elastase to induce emphysema. Seven animals were not ventilated and served as
controls (NV). Twenty-eight animals were anesthetized and assigned to mechanical
ventilation with a VT CV of 0% (BASELINE). After data collection, animals (n = 7/group)
were randomly allocated to VT CVs of 0% (VV0); 15% (VV15); 22.5% (VV22.5); or 30%
(VV30). In all groups, mean VT was 6 mL/kg and positive end-expiratory pressure was
3 cmH2O. Respiratory system mechanics and cardiac function (by echocardiography)
were assessed continuously for 2 h (END). Lung histology and molecular biology were
measured post-mortem. VV22.5 and VV30 decreased respiratory system elastance,
while VV15 had no effect. VV0, VV15, and VV22.5, but not VV30, increased pulmonary
acceleration time to pulmonary ejection time ratio. VV22.5 decreased the central moment
of the mean linear intercept (D2 of Lm) while increasing the homogeneity index (1/β)
compared to NV (77 ± 8µm vs. 152 ± 45µm; 0.85 ± 0.06 vs. 0.66 ± 0.13, p
< 0.05 for both). Compared to NV, VV30 was associated with higher interleukin-6
expression. Cytokine-induced neutrophil chemoattractant-1 expression was higher in
all groups, except VV22.5, compared to NV. IL-1β expression was lower in VV22.5 and
VV30 compared to VV0. IL-10 expression was higher in VV22.5 than NV. Club cell
protein 16 expression was higher in VV22.5 than VV0. SP-D expression was higher in
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VV30 than NV, while SP-C was higher in VV30 and VV22.5 than VV0. In conclusion,
VV22.5 improved respiratory system elastance and homogeneity of airspace enlargement,
mitigated inflammation and epithelial cell damage, while avoiding impairment of right
cardiac function in experimental elastase-induced emphysema.
Keywords: variable ventilation, respiratory system elastance, cardiorespiratory function, lung morphometry,
inflammation, surfactant protein-D
INTRODUCTION
The need for ventilator support in chronic obstructive pulmonary
disease (COPD) is a result of respiratory failure (MacIntyre
and Huang, 2008) due to a persistent chronic inflammatory
response (GOLD, 2017). Noninvasive ventilation is widely
used in COPD patients and is associated with shorter length
of hospital stay, lower mortality rates, and lower costs as
compared to invasive methods (Lindenauer et al., 2014). On
the other hand, patients with more severe disease may still
require invasive mechanical ventilation (Stefan et al., 2015a,b).
In volume-controlled mechanical ventilation, due to its inherent
monotonous pattern, the amplitude and duration of inflation
and deflation are comparable. This, taking into account the
time-constant inhomogeneity observed in COPD, can lead to
delayed inflation of some lung areas and overdistension in others
(Laghi et al., 2001; MacIntyre and Huang, 2008). This scenario
may predispose to the development of ventilator-induced lung
injury (VILI), further increasing the impedance of the pulmonary
vascular bed and worsening the impact of mechanical ventilation
on right ventricular (RV) function, which is already impaired in
COPD (Vieillard-Baron et al., 1999; Wrobel et al., 2015).
Variable ventilation (VV), which is characterized by breath-
to-breath variation of tidal volume (VT), has been shown to
improve oxygenation (Lefevre et al., 1996) and respiratory
function (Mutch et al., 2000; Spieth et al., 2009b; Thammanomai
et al., 2013) reducing lung damage in models of acute lung
injury (Kiss et al., 2016). Such beneficial effects have been
ascribed to the potential of VV to recruit the lungs (Ruth
Graham et al., 2011), redistribute pulmonary perfusion (Gama
de Abreu et al., 2008), increase surfactant release (Arold et al.,
2009), and even reduce the pro-inflammatory response of type-I
alveolar epithelial cells (Rentzsch et al., 2017). Importantly, VV
also improves distribution of ventilation across lung areas with
different time constants (Huhle et al., 2016).
Recently, our group showed that variable tidal volumes set
to a 30% coefficient of variation (CV) may result in a more
homogenous distribution of ventilation, but might also impair
right heart function in an elastase-induced emphysema model
(Henriques et al., 2016). This setting of 30% CV was based on
experiments performed in models of acute lung injury (Spieth
et al., 2009b; Kiss et al., 2016). In theory, since emphysema and
acute lung injury present distinct lung structural and functional
changes, we hypothesized that a different setting of CV could
improve both lung and cardiovascular function in experimental
elastase-induced emphysema.
In the present study, we sought to determine the effects of
different levels of CV on: (1) respiratory system elastance (E) and
resistance (R); (2) gas exchange; (3) cardiac function, which was
assessed by echocardiography measuring cross-sectional right
and left ventricular diastolic areas (RV and LV, respectively),
pulmonary acceleration time (PAT) to pulmonary ejection time
(PET) ratio (PAT/PET) (an indirect index of pulmonary arterial
hypertension), and left ventricular ejection fraction (EF) and
fractional shortening (FS); and (4) gene expressions of biological
markers associated with inflammation, epithelial cell damage,
mechanical cell stress, and fibrogenesis in lung tissue.
MATERIALS AND METHODS
Ethics Statement
This study was approved by the Ethics Committee of the Health
Sciences Center (CEUA-CCS 059-15), Federal University of Rio
de Janeiro. Animals received humane care in compliance with the
Principles of Laboratory Animal Care formulated by the National
Society for Medical Research and the U.S. National Academy of
Sciences Guide for the Care and Use of Laboratory Animals.
Animal Preparation and Experimental
Protocol
The time course of interventions is depicted in Figure 1.
Emphysema was induced in 35 Wistar rats (weight 437 ± 25 g)
according to a protocol described in detail elsewhere (Henriques
et al., 2016). Briefly, animals received porcine pancreatic elastase
(PPE) (2 IU in 0.1mL of saline solution, Sigma Chemical Co.,
St. Louis, MO, USA) intratracheally, once weekly for 4 weeks.
Before each intratracheal instillation, animals were premedicated
with intraperitoneal diazepam (10 mg/kg, Compaz R©, Cristália,
Itapira, SP, Brazil) and anesthetized with 1.5–2.0% isoflurane
(Cristália, SP, Brazil) bymask. Five weeks after the last instillation,
experiments were performed.
Seven animals were non-ventilated (NV), serving as a
control group. The remaining 28 animals were anesthetized
with intraperitoneal diazepam (10 mg/kg, Compaz R©, Cristália,
Itapira, SP, Brazil), ketamine (50–100 mg/kg, Ketamin-S+ R©,
Cristália, Itapira, SP, Brazil), and midazolam (2 mg/kg,
Dormire R©, Cristália, Itapira, SP, Brazil). An intravenous catheter
(Jelco 24G) was inserted into the tail vein for continuous
infusion of midazolam (2 mg/kg/h), ketamine (50 mg/kg/h),
and Ringer’s lactate (7 mL/kg/h, B. Braun, Crissier, Switzerland).
Anesthetized animals were kept in the dorsal recumbent
position and tracheotomized via a midline neck incision
after subcutaneous injection of 2% lidocaine (Xylestesin R©,
Cristália, Itapira, SP, Brazil). The right internal carotid artery
was cannulated (18G, Arrow International, USA) for blood
sampling andmean arterial pressure (MAP) measurement. Heart
rate (HR), MAP, and rectal temperature were continuously
monitored (Networked Multiparameter Veterinary Monitor
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FIGURE 1 | Design and timeline of experiments. PPE: porcine pancreatic elastase; NV: non-ventilated animals; VV: variable ventilation; VT: tidal volume; CV: coefficient
of variation; RR: respiratory rate; I:E: inspiratory/expiratory ratio; PEEP: positive end-expiratory pressure; FiO2: fraction of inspired oxygen.
LifeWindow 6000V, Digicare Animal Health, Florida, USA).
Body temperature was maintained at 37.5 ± 1◦C using a
heating bed. Gelafundin R© 4% (B. Braun, São Gonçalo, RJ,
Brazil) was administered intravenously in 0.5-mL boluses as
needed to keep MAP ≥70 mmHg. Neuromuscular blockade
was achieved by intravenous administration of pancuronium
bromide (2 mg/kg, Pancuron R©, Cristália, Itapira, SP, Brazil)
and animals were mechanically ventilated (Inspira R©, Harvard
Apparatus, Holliston, Massachusetts, USA) in VCV mode with
VT = 6 mL/kg, respiratory rate (RR) adjusted to maintain
arterial pH in the 7.35–7.45 range, inspired oxygen fraction
(FIO2) = 0.4, and positive end-expiratory pressure (PEEP) =
3 cmH2O. After hemodynamic stabilization, respiratory system
mechanics, arterial blood gases (Radiometer ABL80 FLEX,
Copenhagen NV, Denmark), and echocardiographic parameters
were measured (BASELINE). Following this step, animals were
randomly assigned using the sealed-envelope method to one
of four mechanical ventilation groups (n = 7/group), based
on the CV of VT: (1) 0% (VV0); (2) 15% (VV15); (3)
22.5% (VV22.5); or (4) 30% (VV30). VV was applied on a
breath-to-breath basis as a sequence of randomly generated
VT values (Gaussian distribution, n = 1200; mean VT = 6
mL/kg), according to adjusted CV of VT (nVentInspira) (Huhle
et al., 2014), for 2 h. At the end of the experiment (END),
echocardiographic parameters, respiratory system mechanics,
and arterial blood gases were analyzed. Heparin (1000 IU)
was injected intravenously; animals were killed by overdose
of intravenous sodium thiopental (50 mg/kg, Thiopentax R©,
Cristália, Itapira, SP, Brazil) and their lungs extracted at PEEP =
3 cmH2O for lung morphometry and molecular biology analyses
(Figure 1).
Echocardiography
Shaved animals were placed in the dorsal recumbent position.
Transthoracic echocardiography was performed by an expert
(NNR) blinded to group allocation, using an UGEO HM70A
system (Samsung, São Paulo, Brazil) equipped with a linear
phased-array probe (8–13 MHz). Images were obtained from
the subcostal and parasternal views. Short-axis two-dimensional
views were acquired at the level of the papillary muscles to
measure LV and RV areas. Left ventricular fractional shortening
(FS) was calculated in M-mode, while the ejection fraction
(EF) was obtained by multiplying LV outflow tract area by the
volume time integral (VTI) on the LV long parasternal view.
Pulsed-wave Doppler was used to measure PAT, PET, and the
PAT/PET ratio. Heart ratio (HR) and the diameter of the inferior
vena cava (IVC) and right atrium (RA) were assessed from the
subcostal view. All parameters followed American Society of
Echocardiography and European Association of Cardiovascular
Imaging recommendations (Thibault et al., 2010; Lang et al.,
2015).
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Data Acquisition and Respiratory System
Mechanics
Airflow, volume, and airway pressure were continuously
recorded with a computer running custom software written
in LabVIEW (National Instruments; Austin, Texas, USA)
(Silva et al., 2013). All signals were amplified in a three-
channel signal conditioner (TAM-D HSE Plugsys Transducers
Amplifiers, Module Type 705/2, Harvard Apparatus, Holliston,
Massachusetts, USA) and sampled at 1,000Hz with a 12-bit
analog-to-digital converter (National Instruments; Austin, Texas,
USA). E and R were calculated oﬄine based on the equation of
motion (Uhlig et al., 2014).
Lung Morphometry
Morphometric analysis was performed in lungs excised at end-
expiration (PEEP = 3 cmH2O). Immediately after removal,
the left lung was flash-frozen by immersion in liquid nitrogen,
fixed with Carnoy’s solution, and paraffin-embedded. Sections
(4µm thick) were cut and stained with hematoxylin and eosin.
An investigator (MSC) blinded to the origin of the material
performed the microscopic examination. Morphometric analysis
was done using an integrating eyepiece with a coherent system
made of a 100-point grid, consisting of 50 lines of known length,
coupled to a conventional light microscope (Axioplan, Zeiss,
Oberkochen, Germany). Airspace enlargement was assessed by
measuring the mean linear intercept (Lm) between alveolar walls
at a magnification of ×400 (Hsia et al., 2010). To characterize
the heterogeneity of airspace enlargement, the central moment
of the mean linear intercept (D2 of Lm) was computed from 20
airspace measurements (Parameswaran et al., 2006), according to
Equation 1:
D2 = µ ·
(
1+
σ2
µ2 + σ2
)
·
(
2+ σ ·
γ
µ
)
(1)
where µ is the mean, σ the variance of airspace diameters, and γ
the skewness of the diameter distribution. After D2 calculation,
the homogeneity index (1/β) was derived from Lm and D2 values
by their ratio.
Molecular Biology
Quantitative real-time reverse transcription polymerase chain
reaction (qRT-PCR) was performed to assess the gene expression
of interleukin (IL)-6, IL-1β, and IL-10, cytokine-induced
neutrophil chemoattractant (CINC)-1, amphiregulin, surfactant
protein (SP)-D and SP-C, club cell protein (CC)16, and type
III procollagen (PCIII). Central slices of the right lung were
cut, collected in cryotubes, flash-frozen by immersion in liquid
nitrogen, and stored at −80◦C. Total RNA was extracted from
frozen tissues using the RNeasyPlus Mini Kit (Qiagen, Hilden,
Germany) following the manufacturer’s recommendations.
RNA concentration was measured by spectrophotometry in a
NanoDrop ND-1000 system (Thermo Scientific, Wilmington,
DE, USA). First-strand cDNA was synthesized from total
RNA using a QuantiTect reverse transcription kit (Qiagen,
Hilden, Germany). The primers used are described in the
online supplement (Table S1). Relative mRNA levels were
measured by SYBR Green-based detection in an ABI 7500 Real-
Time PCR system (Applied Biosystems, Foster City, California,
USA). Samples were run in triplicate. For each sample, the
expression of each gene was normalized to the acidic ribosomal
phosphoprotein P0 (36B4) housekeeping gene and expressed as
fold change relative to NV animals, using the 2−11Ct method,
where1Ct= Cttarget gene − Ctreference gene.
Statistical Analysis
Effect-size estimates were based on a previous study using the
elastase instillation model of emphysema. A sample size of 7
animals per group would provide appropriate power (1–β= 0.8)
to identify significant (α = 0.05) differences in E, taking into
account an effect size d = 2.21, equal number of animals per
group, a two-sided t-test, and multiple comparisons (n = 6) (α∗
= 0.008, Bonferroni-adjusted) (G∗Power 3.1.9.2, University of
Düsseldorf, Germany).
Changes in variables between BASELINE and END were
tested with a paired t-test. Two-way repeated-measures ANOVA
followed by Holm-Šídák’s multiple comparisons was used to
compare cardiorespiratory function parameters among groups,
while one-way ANOVA followed by Holm-Šídák’s multiple
comparisons was used to compare lung morphometry between
NV and each CV group. Molecular biology variables were
compared using the Kruskal–Wallis test followed by Dunn’s
multiple comparisons. Parametric data were expressed as mean
± standard deviation (SD) and non-parametric data as median
(interquartile range). Associations of E with SP-D and SP-
C were assessed using Spearman’s correlation. All tests were
performed in GraphPad Prism v6.07 (GraphPad Software, La
Jolla, California, USA).
RESULTS
Respiratory and blood gas-exchange variables at BASELINE and
END are reported in Table 1. VT, minute ventilation (V
′
E), R, and
PEEP levels did not differ among groups. As expected, the CV
of VT increased progressively across groups from VV0 to VV30.
Compared to BASELINE, E was increased in VV0 and decreased
in VV22.5, and VV30, which showed the lowest value at END.
The arterial partial pressure of oxygen (PaO2) increased from
BASELINE to END in all groups.
As depicted in Table 2, HR, MAP, cumulative fluids, IVC,
RA, PET, LV area, EF, and FS did not differ among groups. RV
area decreased from BASELINE to END in VV0, but increased
in VV30. At END, VV22.5 and VV30 animals had larger RV
area values than VV0; these were highest in VV30 compared
to the other groups. Figure 2 shows the PAT/PET ratio and
tracing of blood flow velocity measured at the pulmonary artery
in representative animals. Compared to BASELINE, PAT/PET
increased in all groups except VV30 at END, mainly due to
increases in PAT, as shown in Table 2. Furthermore, VV30
animals had lower PAT/PET values compared to VV0 and VV15
animals.
Figure 3 depicts light microscopy images of one
representative animal per group. Morphometric data are
shown in Table 3. VV22.5 presented the lowest values of mean
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TABLE 1 | Respiratory and blood gas exchange parameters at BASELINE and after 2 h (END).
VV0 VV15 VV22.5 VV30
VT
(mL/kg)
BASELINE 6.0 ± 0.0 6.0 ± 0.0 6.0 ± 0.1 6.0 ± 0.1
END 6.0 ± 0.1 6.0 ± 0.0 6.0 ± 0.1 6.1 ± 0.1
CV of VT
(%)
BASELINE 2.5 ± 1.9 1.2 ± 0.5 1.6 ± 0.7 1.4 ± 0.6
END 1.6 ± 0.3 15.4 ± 0.9* #‡ § 23.4 ± 1.3* #† § 28.8 ± 2.1*#†‡
V
′
E
(mL/min)
BASELINE 149.5 ± 2.9 150.4 ± 1.9 149.8 ± 2.3 149.9 ± 2.3
END 149.7 ± 2.1 153.1 ± 7.6 150.9 ± 3.6 151.8 ± 4.9
E
(cmH2O/mL)
BASELINE 3.2 ± 0.5 3.3 ± 0.4 3.2 ± 0.6 3.0 ± 0.6
END 3.6 ± 0.3* 3.2 ± 0.3 2.8 ± 0.2* 2.4 ± 0.2*#†
R
(cmH2O/mL/s)
BASELINE 0.21 ± 0.04 0.20 ± 0.03 0.18 ± 0.02 0.19 ± 0.02
END 0.18 ± 0.01 0.18 ± 0.04 0.16 ± 0.01 0.17 ± 0.02
PEEP
(cmH2O)
BASELINE 3.2 ± 0.3 3.2 ± 0.2 3.2 ± 0.2 3.0 ± 0.4
END 3.2 ± 0.3 3.2 ± 0.1 3.3 ± 0.3 3.1 ± 0.3
pHa BASELINE 7.40 ± 0.02 7.38 ± 0.03 7.40 ± 0.05 7.41 ± 0.02
END 7.35 ± 0.04 7.36 ± 0.04 7.36 ± 0.06 7.37 ± 0.07
PaO2
(mmHg)
BASELINE 139 ± 37 134 ± 38 133 ± 34 134 ± 37
END 176 ± 21* 191 ± 18* 179 ± 26* 173 ± 20*
PaCO2
(mmHg)
BASELINE 37.7 ± 1.5 37.3 ± 3.1 38.4 ± 6.9 34.1 ± 3.0
END 43.3 ± 5.3 36.6 ± 5.6 36.9 ± 8.0 38.3 ± 5.1
HCO3
(mmol/L)
BASELINE 23.6 ± 1.2 21.7 ± 1.6 23.4 ± 3.0 21.4 ± 2.3
END 23.3 ± 3.4 20.4 ± 2.7 19.8 ± 2.7 21.8 ± 2.7
Values are mean ± standard deviation (SD) of 7 emphysema animals in each group, exposed to elastase and analyzed 5 weeks after the last instillation. VV0: variable ventilation with 0%
coefficient of variability in tidal volume; VV15: variable ventilation with 15% coefficient of variability in tidal volume; VV22.5: variable ventilation with 22.5% coefficient of variability in tidal
volume; VV30: variable ventilation with 30% coefficient of variability in tidal volume; VT : tidal volume; CV of VT : coefficient of variation of tidal volume; V′E: minute ventilation; E: respiratory
system elastance; R: respiratory system resistance; PEEP: positive end-expiratory pressure; pHa: arterial pH; PaCO2: arterial partial pressure of carbon dioxide; PaO2: arterial partial
pressure of oxygen; HCO3: bicarbonate. Paired t-tests were used to compare BASELINE and END. * vs. BASELINE (p < 0.05). Comparisons among ventilated groups were performed
by two-way repeated-measures ANOVA followed by Holm-Šídák’s multiple comparisons test; # vs. VV0 (p < 0.05);
† vs. VV15 (p < 0.05); ‡ vs. VV22.5 (p < 0.05); § vs. VV30 (p < 0.05).
linear intercept (Lm) among all groups, as well as a lower D2 of
Lm compared to NV. Accordingly, the homogeneity index 1/β
was higher in VV22.5 than in NV.
Gene expressions of amphiregulin and PCIII did not differ
among groups. CC16 expression was higher in VV22.5 than
VV0. Gene expression of SP-D was higher in VV30 than NV,
while SP-C expression was higher in VV30 and VV22.5 than
VV0 (Figure 4). Compared to NV, VV30 showed higher IL-6
expression. CINC-1 expression was higher in all groups except
VV22.5 when compared to NV. IL-1β expression was lower in
VV22.5 and VV30 compared to VV0. IL-10 mRNA expression was
higher in VV22.5 than NV (Figure 5).
E correlated negatively with gene expressions of SP-D (r =
−0.55, p= 0.007) and SP-C (r =−0.62, p= 0.002).
Table 4 depicted the positive and negative percentage
alterations of the mean values in each group at END compared to
BASELINE. Progressive improvement in E is noticeable, whereas
PAT (the main contributor to PAT/PET ratio) deteriorated,
suggesting pulmonary arterial hypertension. PaO2 improved in
all groups compared to BASELINE.
DISCUSSION
The main findings of the present study were that, in a rat
model of experimental emphysema: VV22.5 and VV30 decreased
E, while VV15 did not affect it; VV, regardless of CV, did not
improve gas exchange; VV0, VV15, and VV22.5, but not VV30,
increased PAT/PET; VV22.5 was associated with the lowest Lm,
while increasing the homogeneity index compared to NV; CINC-
1 and IL-1β expressions were lower in VV22.5 compared to NV
and VV0, respectively; CC16 and IL-10 expressions were higher
in VV22.5 compared to VV0 and NV, respectively; and VV30
led to higher expressions of SP-C and SP-D than VV0 and NV,
respectively.
To the best of our knowledge, this was the first investigation
of the effects of different levels of VT variability on pulmonary
and cardiovascular function, lung morphometry, and gene
expression of markers of inflammation, surfactant proteins,
epithelial cell damage, cell mechanical stress, and fibrogenesis in
experimental emphysema. We chose the repeated intratracheal
elastase instillation model because it reproduces important
features of emphysema, including deterioration of respiratory
system mechanics, airspace enlargement, and lung inflammation
(Antunes and Rocco, 2011; Cruz et al., 2012; Henriques et al.,
2016; Oliveira et al., 2016; Padilha et al., 2016; Rocha et al., 2017;
Suki et al., 2017). Furthermore, multiple elastase instillations
can lead to cardiorespiratory alterations (Antunes et al., 2014)
that are consistent with cor pulmonale, including increased RV
afterload (Henriques et al., 2016). We chose to conduct analyses
5 weeks after the last elastase instillation because this time point
provides an adequate combination of cardiorespiratory function
impairment and structural lung damage (Henriques et al., 2016).
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TABLE 2 | Hemodynamics, cumulative fluids, and echocardiography data.
VV0 VV15 VV22.5 VV30
HR (bpm) BASELINE 367 ± 75 351 ± 60 411 ± 66 348 ± 46
END 351 ± 67 357 ± 52 371 ± 60 319 ± 89
MAP (mmHg) BASELINE 116 ± 43 132 ± 17 133 ± 39 115 ± 26
END 129 ± 17 105 ± 24 106 ± 36 118 ± 22
Cumulative fluids (mL) BASELINE – – – –
END 6.7 ± 1.9 7.5 ± 1.5 9.0 ± 2.2 6.5 ± 1.0
IVC diameter (cm) BASELINE 0.19 ± 0.07 0.23 ± 0.09 0.14 ± 0.03 0.20 ± 0.06
END 0.20 ± 0.10 0.21 ± 0.08 0.12 ± 0.03 0.21 ± 0.11
RA diameter (cm) BASELINE 0.38 ± 0.05 0.43 ± 0.04 0.36 ± 0.05 0.40 ± 0.07
END 0.36 ± 0.05 0.40 ± 0.03 0.30 ± 0.03 0.39 ± 0.05
RV area (cm2) BASELINE 0.34 ± 0.06 0.38 ± 0.07 0.34 ± 0.07 0.37 ± 0.07
END 0.28 ± 0.05* 0.39 ± 0.11 0.33 ± 0.05# 0.46 ± 0.12*#‡
PAT (ms) BASELINE 20.7 ± 8.6 22.3 ± 7.5 19.2 ± 5.4 22.6 ± 7.8
END 28.9 ± 9.8* 33.3 ± 12.1* 25.2 ± 5.5* 17.3 ± 8.3
PET (ms) BASELINE 65.1 ± 18.9 69.0 ± 14.5 62.0 ± 8.5 68.8 ± 9.6
END 65.0 ± 16.7 61.6 ± 13.4 56.9 ± 9.3 58.1 ± 13.6
LV area (cm2) BASELINE 0.14 ± 0.04 0.12 ± 0.03 0.16 ± 0.08 0.13 ± 0.04
END 0.20 ± 0.05 0.13 ± 0.04 0.19 ± 0.10 0.16 ± 0.08
EF (%) BASELINE 95.2 ± 3.9 95.1 ± 2.3 95.7 ± 3.4 93.2 ± 6.6
END 92.1 ± 5.4 89.5 ± 7.3 95.3 ± 1.9 87.9 ± 9.2
FS (%) BASELINE 67.8 ± 9.2 66.4 ± 6.3 68.7 ± 9.2 64.4 ± 13.2
END 61.7 ± 12.3 54.4 ± 12.8 66.1 ± 5.2 55.9 ± 14.3
Values are mean ± standard deviation (SD) of 7 animals in each group, exposed to elastase and analyzed 5 weeks after the last instillation. HR: heart rate; MAP: Mean arterial pressure;
IVC: inferior vena cava; RA: right atrium RV: right ventricle; PAT: pulmonary acceleration time; PET: pulmonary ejection time; LV: left ventricle; EF: ejection fraction; FS: fractional shortening.
Paired t-tests were used to compare BASELINE and END; * vs. BASELINE (p < 0.05). Comparisons among ventilated groups were performed by two-way repeated-measures ANOVA
followed by Holm-Šídák’s multiple comparisons test; # vs. VV0 (p < 0.05);
† vs. VV15 (p < 0.05); ‡ vs. VV22.5 (p < 0.05); § vs. VV30 (p < 0.05).
FIGURE 2 | Cardiovascular function was assessed by echocardiography. Upper panel: PAT, pulmonary acceleration time; PET, pulmonary ejection time. Data
presented as mean and standard deviation of 7 animals in all groups. The PAT/PET ratio was used as an indirect index of pulmonary arterial hypertension.
(*) Significantly different from BASELINE (p < 0.05). Lower panel: representative images of pulmonary blood flow.
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FIGURE 3 | Representative light microscopy images. Original magnification ×200.
TABLE 3 | Lung morphometry in mechanically ventilated animals.
NV VV0 VV15 VV22.5 VV30
Lm (µm) 96 ± 10 89 ± 13 89 ± 13 70 ± 6*#†§ 88 ± 15
D2 of Lm (µm) 152 ± 45 131 ± 39 120 ± 45 82 ± 9* 117 ± 27
1/β 0.66 ± 0.13 0.70 ± 0.13 0.78 ± 0.14 0.85 ± 0.06* 0.76 ± 0.10
Values are mean ± standard deviation (SD) of 7 animals in each group, exposed to elastase and analyzed 5 weeks after the last instillation. NV: non-ventilated; VV0: variable ventilation
with 0% coefficient of variability in tidal volume; VV15: variable ventilation with 15% coefficient of variability in tidal volume; VV22.5: variable ventilation with 22.5% coefficient of variability
in tidal volume; VV30: variable ventilation with 30% coefficient of variability in tidal volume; Lm: mean linear intercept; D2: central moments of mean linear intercept; 1/β: homogeneity
index. Comparisons were performed by one-way analysis of variance followed by Holm-Šídák’s multiple comparisons test. * vs. NV (p < 0.05); # vs. VV0 (p < 0.05);
† vs. VV15 (p <
0.05); § vs. VV30 (p < 0.05).
The levels of VT variability were selected on the basis of our
previous experience with variable ventilation in models of acute
lung injury (Spieth et al., 2009b; Kiss et al., 2016); these studies
showed that the optimal CV is situated in the range of 15 to 30%
of VT.
Our finding that VV improved E is in agreement with
studies in models of acute lung injury (Thammanomai et al.,
2008; Spieth et al., 2009a; de Magalhaes et al., 2016; Kiss
et al., 2016; Samary et al., 2016) and emphysema (Henriques
et al., 2016). VV is able to recruit the lungs more efficiently
than conventional recruitment maneuvers (Thammanomai et al.,
2008; Spieth et al., 2009b), leading to an increase in aerated lung
tissue (Ruth Graham et al., 2011) with consequent improvement
of viscoelastic properties. In this line, Thammanomai et al.
(2008) showed that, in injured mice, variable ventilation, but not
conventional ventilation with periods of large breaths, resulted
in less lung inflammation. In emphysema, a substantial degree of
small airway narrowing can be present (McDonough et al., 2011),
but deep inspirations, which are present sporadically during VV,
have been shown to revert this (Wong et al., 2012). In addition,
the fact that VV applies subphysiological VT values may have
helped limit hyperinflation during mechanical ventilation and
promote emptying of lung regions with lower time constants.
Although we did not observe differences in overall resistance,
we cannot exclude that regional resistance might have been
affected by tissue destruction (Hantos et al., 2008), as detected
by better homogeneity index in lung morphometry. It is worth
noting that elastance improved continuously with increasing
variability in VT, and was lowest at VV30. Curiously, this behavior
is similar to that described during VV in experimental acute
lung injury (Spieth et al., 2009a), and the lack of a “U-shape”
is likely explained by the fact that the highest variability was
limited to a CV of 30%, which corresponds to a peak VT
around 10–12 mL/kg. Up to this VT level, we were likely still
located on the linear portion of the respiratory system pressure–
volume curve (Ito et al., 2005). Our data also suggest that
the improvement in elastance might be related to an increase
in surfactant production. Release of surfactant is known to
be models (Bartolak-Suki et al., 2017) and variable stretch of
alveolar epithelial cells (Arold et al., 2009). Although we did
not evaluate the cellular mechanisms of surfactant production in
detail, mechanical stretch has been shown to stimulate surfactant
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FIGURE 4 | Quantitative real-time polymerase chain reaction analysis of biological markers of club cell protein (CC)-16, alveolar epithelial cells [surfactant proteins
(SP)-C, SP-D], mechanical cell stress (amphiregulin), and fibrogenesis [type III procollagen (PCIII)]. Data are presented as a box plot. Lines denote the median and
boxes delimit the 25th and 75th percentiles of 7 animals per group. Relative gene expression was calculated as a ratio of the average gene expression levels
compared with the reference gene (36B4) and expressed as fold change relative to NV. *Significantly different from NV group (p < 0.05); #Significantly different from
VV0 group (p < 0.05).
production through epidermal growth factor receptor (EGFR)
phosphorylation (Sanchez-Esteban et al., 2004). In addition,
one possible explanation for the increase in surfactant mRNA
synthesis would be improvement in overall cell bioenergetics. In
this context, variable stretch has been shown to improve ATP
production by promoting mitochondrial biogenesis, which, in
turn, led to structural changes such as increased organization
of the actin, microtubule, and mitochondrial networks, as
characterized by their fractal dimension and coefficient of
variation (Bartolak-Suki et al., 2015). By promoting cytoskeleton
organization, the alveolar epithelial cells are more prone to start
or continue surfactant synthesis into the alveolar space (Singh
et al., 2004).
Interestingly, oxygenation increased in all groups but was
not further improved by VV, suggesting that a time-dependent
recruitment effect occurred. This is likely explained by the use
of PEEP in all groups. Furthermore, we cannot exclude the
possibility that redistribution of perfusion without significant
degrees of recruitment was present. In fact, VV has been shown
to improve oxygenation even when the fraction of non-aerated
lung tissue increases (Gama de Abreu et al., 2008).
In agreement with a previous study from our group
(Henriques et al., 2016), VV30 did not improve PAT/PET,
but increased RV area. Taken together, the findings of these
studies indicate that higher VT variability impairs right heart
function. The present study, however, adds to the present state of
knowledge. Intermediate levels of variability, namely VV15 and
VV22.5, improved PAT/PET to a similar extent as VV0, limiting
impact on right ventricular afterload. One possible explanation
for this behavior is that both excessive and insufficient lung-unit
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FIGURE 5 | Quantitative real-time polymerase chain reaction analysis of biological markers of inflammation: interleukin (IL)-6, IL-1β, IL-10, and cytokine-induced
neutrophil chemoattractant (CINC)-1. Data are presented as a box plot. Lines denote the median and boxes delimit the 25th and 75th percentiles of 7 animals per
group. Relative gene expression was calculated as a ratio of the average gene expression levels compared with the reference gene (36B4) and expressed as fold
change relative to NV. *Significantly different from NV group (p < 0.05). #Significantly different from VV0 group (p < 0.05).
TABLE 4 | Mean percent changes for several parameters during VV0, VV15,
VV22.5, and VV30 compared to BASELINE.
%VV0 %VV15 %VV22.5 %VV30
E (cmH2O/mL) +15.4 −3.8 −10.5 −17.6
PAT (ms) +50.0 +46.2 +35.4 −20.7
PET (ms) +4.9 −7.2 −7.0 −15.3
PAT/PET +50.3 +58.0 +73.6 −4.4
RV area (cm2) −17.9 +1.5 −2.2 +25.5
PaO2 (mmHg) +32.7 +50.9 +42.2 +43.3
Positive and negative mean percent changes in several parameters in each group
compared to BASELINE (n = 7 emphysema animals). VV0: variable ventilation with 0%
coefficient of variability in tidal volume; VV15: variable ventilation with 15% coefficient of
variability in tidal volume; VV22.5: variable ventilation with 22.5% coefficient of variability in
tidal volume; VV30: variable ventilation with 30% coefficient of variability in tidal volume;
E: respiratory system elastance; PAT: pulmonary acceleration time; PET: pulmonary
ejection time; RV: right ventricle; PaO2: arterial partial pressure of oxygen. Only statistically
significant findings are presented.
recruitment, which have been observed at extremes of VT
variability, led to high or low lung volumes respectively, thus
increasing pulmonary vascular resistance (Simmons, 1961). This
hypothesis is supported by our observation that an intermediate-
to-high level of variability, namely VV22.5, resulted in a more
homogeneous and less pronounced airspace enlargement, as
suggested by lower Lm and D2 and higher homogeneity index
(Parameswaran et al., 2006). In addition to opening the lungs
and keeping them homogeneously opened, VV22.5 may better
distribute mechanical forces, thus mitigating ventilator-induced
injury. Even though IL-6 expression did not differ between VV0
and VV22.5, expression of other pro-inflammatory mediators,
such as CINC-1 and IL-1β, was reduced in VV22.5, whereas gene
expression of anti-inflammatory IL-10 increased. Differences
in the behaviors of these pro-inflammatory mediators may be
associated with the pathophysiology of emphysema and with
differential cell activation during VILI.
Interestingly, despite improvement in respiratory system
mechanics, gene expression of IL-6 was increased at VV30. This
finding is in agreement with a previous study from our group
showing that conventional and variable mechanical ventilation
with a CV of 30% resulted in increased lung inflammation
in experimental emphysema (Henriques et al., 2016). In this
context, a recent study reported a significant reduction in IL-
6 gene expression after 4 h of variable cyclic stretch in LPS-
stimulated alveolar cells (similar to 30% of CV of VT in vivo) as
compared to monotonous cyclic stretch (Rentzsch et al., 2017).
These effects were potentially mediated by the ERK1/2 pathway
after mechanical stress. Activation of the ERK1/2 pathway by
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cell stretch reflects prior activation of TNFR-associated factors
(TRAFs), mainly TRAF2 (Sotoudeh et al., 2002), which is
critical to IKK activation. Once TRAFs are activated, this may
elicit activation of NF-κB and AP-1 (Oeckinghaus et al., 2011),
resulting in increased inflammatory gene expression. Although
we did not measure ERK1/2 and TRAF, we speculate that, even
taking into account the fragile tissue observed in emphysema
(Suki et al., 2013), VV22.5 might not trigger this inflammatory
pathway.
Importantly, variable ventilation did not result in increased
cell mechanical stress or fibrogenesis, as indicated by
amphiregulin and PCIII gene expressions, respectively.
Nevertheless, VV22.5 positively modulated CC16 expression.
CC16 is synthesized predominantly in the lungs, but also
found in the circulation. Serum CC16 has been reported to
decrease with lung disease progression (Vestbo et al., 2011)
and smoking, and is considered a marker of bronchial cell
dysfunction (Park et al., 2013). In this line, CC16 has been shown
to play a protective role in COPD (Laucho-Contreras et al.,
2015), and its levels should be maintained to protect the lungs
from progression of COPD-like disease (Park et al., 2013). In
the present study, VV22.5 resulted in higher CC16 expression
compared to VV0.
Possible Implications for Further Studies
Our data suggest that, in patients with emphysema who require
invasive mechanical ventilation, variation in tidal volumes may
contribute to improved E and reduce the inhomogeneity of
airspace enlargement, especially if a VT CV of 22.5% is used.
This variability level can also reduce the likely negative impact
of variable ventilation on right heart function without increasing
the pro-inflammatory and pro-fibrotic lung response. Clinical
studies are necessary to determine the potential role of variable
ventilation within this CV range in emphysema.
LIMITATIONS
This study has several limitations. First, the emphysema model
used herein (repeated intratracheal instillation of elastase)
does not entirely reproduce the clinical picture seen in
humans, and cannot be directly extended to other models
of emphysema. Second, the mechanical ventilation period
(2 h) was short. Long-term variable ventilation may lead to
different results on analysis of inflammatory cell infiltration
in lung tissue. Third, since we tested only four levels of
variability, we cannot exclude the possibility that intermediate
levels might lead to different results. Fourth, echocardiography
was not gated by respiratory cycles, which may have affected
measurement of cardiac function parameters. Nevertheless, the
possibility of bias was minimized by the 15-min imaging
periods. Fifth, although there are several forms of tidal volume
distribution, we chose a Gaussian distribution for technical
reasons, local settings, and experience (de Magalhaes et al.,
2016; Henriques et al., 2016; Kiss et al., 2016; Soluri-Martins
et al., 2017). For experts in the field of lung disease, it would
be interesting to compare different distributions in order to
extract the best readout in terms of cardiorespiratory interaction
among them. Sixty, gene expression of biomarkers does
not necessarily translate to increased protein levels; however,
the relatively short period of intervention precluded protein
analysis.
CONCLUSION
In conclusion, VV22.5 improved respiratory system elastance and
homogeneity of airspace enlargement, mitigated inflammation
and epithelial cell damage, while avoiding impairment of
right cardiac function in experimental elastase-induced
emphysema.
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